Kanagasabai Udhayashankar, Sousa Leonardo, Chevalier Michelle S, Gutreuter Steve, Ibraimo Dina, Salimo Sara, Naueia Eva, Daniel Laison, Khan Selma, Ujamma Dawud, Behel Stephanie, Malimane Inacio, Drammeh Bakary
Divsion of Global HIV and TB, Centers for Disease Control and Prevention, Corporate Square, MS E-04, Atlanta, GA, 30329, USA.
Division of Global HIV and TB, Centers for Disease Control and Prevention, Maputo, Mozambique.
Sci Rep. 2025 Jul 1;15(1):20730. doi: 10.1038/s41598-025-03259-2.
Mozambique's National Blood Transfusion Services (NBTS) is tasked with providing safe and available blood but also conducting systematic screening of at-risk potential donors, notifying seropositive blood donors, and linking them to HIV care and treatment services. Potential blood donors who were deferred from donating following a behavioral risk screening and all blood donors who screened seropositive for HIV were notified and offered linkage to HIV testing, care, and treatment services by community-based organizations. A prospective study among HIV-positive blood donors and deferred donors was conducted from May 2019 to July 2020 at Maputo Central Hospital Blood Bank and the National Reference Blood Center. The associations between testing, initiating care and treatment services among HIV-positive blood donors and prospective deferred donors were estimated using fully Bayesian multivariable logistic models and odds ratios. Among 885 prospective blood donors enrolled, 173 (20%) were deferred due to self-reported high-risk behaviors identified through a screening questionnaire, and 712 (80%) passed the behavioral-risk screening tool, donated, and the blood donation tested positive for HIV. There were more than 2.5 times as many male donors as female donors with a positive HIV test, and among the deferred donors, more than 84% were males. 36% (256/712) of seropositive donors and 35% (61/173) of deferred donors were referred to HIV testing services. 62% (158/256) of seropositive donors and 4.9% (3/61) of deferred donors who were successfully referred were linked to care and treatment services, and 96% (152/158) of these seropositive donors and 100% (3/3) of deferred as high-risk donors initiated antiretroviral therapy (ART). Of the three service organizations used, one outperformed the other two in linking seropositive donors to ART treatment. The NBTS can serve as a critical entry point for identifying HIV-positive persons. Improved implementation of risk behavior screening tools is needed and could contribute to early identification and initiation of ART for potential donors. Innovative strategies and solutions by community-based organizations can be used to improve blood donor notification and linkage to HIV testing and treatment services.
莫桑比克国家输血服务局(NBTS)的任务是提供安全且可获取的血液,同时对有风险的潜在献血者进行系统筛查,通知血清学阳性的献血者,并将他们与艾滋病毒护理和治疗服务联系起来。在行为风险筛查后被推迟献血的潜在献血者以及所有艾滋病毒筛查呈阳性的献血者都得到了通知,并由社区组织为他们提供了与艾滋病毒检测、护理和治疗服务的联系。2019年5月至2020年7月,在马普托中心医院血库和国家参考血库对艾滋病毒阳性献血者和推迟献血者进行了一项前瞻性研究。使用全贝叶斯多变量逻辑模型和比值比来估计艾滋病毒阳性献血者和未来推迟献血者的检测、开始护理和治疗服务之间的关联。在登记的885名潜在献血者中,173人(20%)因通过筛查问卷发现的自我报告的高风险行为而被推迟献血,712人(80%)通过了行为风险筛查工具,献血,且献血检测艾滋病毒呈阳性。艾滋病毒检测呈阳性的男性献血者是女性献血者的2.5倍多,在被推迟献血者中,超过84%是男性。36%(256/712)的血清学阳性献血者和35%(61/173)的被推迟献血者被转介到艾滋病毒检测服务。成功被转介的血清学阳性献血者中有62%(158/256)和被推迟献血者中有4.9%(3/61)与护理和治疗服务建立了联系,这些血清学阳性献血者中有96%(152/158)和作为高风险献血者被推迟献血者中有100%(3/3)开始接受抗逆转录病毒治疗(ART)。在使用的三个服务组织中,有一个在将血清学阳性献血者与抗逆转录病毒治疗联系起来方面比其他两个表现更好。国家输血服务局可以作为识别艾滋病毒阳性者的关键切入点。需要改进风险行为筛查工具的实施,这有助于对潜在献血者进行早期识别并开始抗逆转录病毒治疗。社区组织可以采用创新战略和解决方案来改善献血者通知以及与艾滋病毒检测和治疗服务的联系。